Publications by authors named "H-W Kuhlmann"

Article Synopsis
  • - After stopping treatment with natalizumab (NAT), some multiple sclerosis (MS) patients experience a severe worsening of their disease, potentially linked to specific immune cells called Th17 cells.
  • - During NAT therapy, certain Th17 cells gain harmful characteristics, producing inflammatory substances and damaging brain barriers, which could contribute to this rebound effect.
  • - Th17 cells from patients who rebound show a unique pathogenic profile, and studying these changes could help predict the risk of severe disease recurrence after stopping NAT treatment.
View Article and Find Full Text PDF

Pericytes at the blood-brain barrier (BBB) are located between the tight endothelial cell layer of the blood vessels and astrocytic endfeet. They contribute to central nervous system (CNS) homeostasis by regulating BBB development and maintenance. Loss of pericytes results in increased numbers of infiltrating immune cells in the CNS in experimental autoimmune encephalomyelitis (EAE), the mouse model for multiple sclerosis (MS).

View Article and Find Full Text PDF

Neuroinflammation is often associated with blood-brain-barrier dysfunction, which contributes to neurological tissue damage. Here, we reveal the pathophysiology of Susac syndrome (SuS), an enigmatic neuroinflammatory disease with central nervous system (CNS) endotheliopathy. By investigating immune cells from the blood, cerebrospinal fluid, and CNS of SuS patients, we demonstrate oligoclonal expansion of terminally differentiated activated cytotoxic CD8 T cells (CTLs).

View Article and Find Full Text PDF

Background: In colorectal cancer surgery there is a delicate balance between complete removal of the tumor and sparing as much healthy tissue as possible. Especially in rectal cancer, intraoperative tissue recognition could be of great benefit in preventing positive resection margins and sparing as much healthy tissue as possible. To better guide the surgeon, we evaluated the accuracy of diffuse reflectance spectroscopy (DRS) for tissue characterization during colorectal cancer surgery and determined the added value of DRS when compared to clinical judgement.

View Article and Find Full Text PDF

T cells critically depend on reprogramming of metabolic signatures to meet the bioenergetic demands during activation and clonal expansion. Here we identify the transcription factor Nur77 as a cell-intrinsic modulator of T cell activation. Nur77-deficient T cells are highly proliferative, and lack of Nur77 is associated with enhanced T cell activation and increased susceptibility for T cell-mediated inflammatory diseases, such as CNS autoimmunity, allergic contact dermatitis and collagen-induced arthritis.

View Article and Find Full Text PDF

Molecular mechanisms that determine lesion localization or phenotype variation in multiple sclerosis are mostly unidentified. Although transmigration of activated encephalitogenic T cells across the blood-brain barrier (BBB) is a crucial step in the disease pathogenesis of CNS autoimmunity, the consequences on brain endothelial barrier integrity upon interaction with such T cells and subsequent lesion formation and distribution are largely unknown. We made use of a transgenic spontaneous mouse model of CNS autoimmunity characterized by inflammatory demyelinating lesions confined to optic nerves and spinal cord (OSE mice).

View Article and Find Full Text PDF

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) resulting from a breakdown in peripheral immune tolerance. Although a beneficial role of natural killer (NK)-cell immune-regulatory function has been proposed, it still needs to be elucidated whether NK cells are functionally impaired as part of the disease. We observed NK cells in active MS lesions in close proximity to T cells.

View Article and Find Full Text PDF
Article Synopsis
  • Rasmussen encephalitis (RE) is a rare childhood epilepsy characterized by inflammation in one half of the brain and progressive neurological decline.
  • Researchers studied T-cell receptor (TCR) sequencing from various sources in RE patients and found increased CD8(+) T-cells in the blood that correlates with disease severity.
  • The findings suggest that RE involves an immune response targeting brain structures, and treatments like Rituximab or stem cell transplantation affect TCR diversity in specific ways.
View Article and Find Full Text PDF